All posts

How much protein do you need on a GLP-1? What the clinical trials actually show

Studies put lean-mass loss on GLP-1s anywhere from 15% to 60% of weight lost. What the trials found, why the range is so wide, and what predicts where you land.

Published by MALAI
4 min read

What's less settled than the protein target itself is the number everyone repeats to explain why it matters: "up to 40% of weight lost on a GLP-1 can be muscle." It's directionally reasonable, but the actual research tells a more interesting story than one round number — and understanding it explains why two people on the same medication can end up with very different outcomes. This post is why you won't find the bare "40%" anywhere else on this site.

What the trials actually found

The clearest single-trial data point comes from a body-composition substudy of STEP 1, the pivotal trial for semaglutide 2.4mg (Wegovy). Researchers scanned 140 participants with DEXA — the gold-standard body composition measurement — before and after 68 weeks of treatment. The semaglutide group lost 15.0% of body weight, made up of a 19.3% reduction in fat mass and a 9.7% reduction in lean body mass.

That's one data point. It's not the whole picture. A 2024 review in Diabetes, Obesity and Metabolism — specifically about lean mass changes on GLP-1 therapies — pulled together findings across many trials and found something that gets left out of the "40%" shorthand: lean mass accounted for anywhere from 15% to over 60% of total weight lost, depending on the study.

That's a wide range. The review's authors point to population differences, which specific drug was used, and comorbidities as likely explanations — but the practical takeaway is that the number isn't fixed. It moves based on what a person does during treatment, not just which medication they're on.

Why the range is so wide

Two things show up consistently in the research as predictors of where someone lands in that range:

Protein intake. The GLP-1 literature doesn't stand alone here — it sits on top of a much larger body of research on protein and muscle preservation during any weight loss, GLP-1 or not. A systematic review and meta-analysis of protein intake in adults with overweight or obesity found that higher protein diets consistently preserved more muscle mass, strength, and physical function during weight loss than lower-protein diets, across young, middle-aged, and older adults alike.

Resistance training. A small 2025 case series specifically in GLP-1 patients — three people on semaglutide or tirzepatide, each doing resistance training 3–5 days a week while eating 1.6–2.3g of protein per kilogram of fat-free mass — found lean tissue was preserved in all three, and actually increased in two of them, despite significant fat loss. It's a case series, not a randomized trial, so it can't prove cause and effect on its own. But it's directionally consistent with the broader protein-and-training literature, and a larger randomized controlled trial (called LEAN-PREP) designed specifically to test resistance exercise and protein during semaglutide and tirzepatide therapy is now underway.

Put together: the studies showing lean mass loss at the low end of that 15–60% range tend to involve more protein and more resistance training. The studies at the high end tend not to. That's not a guarantee for any one person, but it's the most actionable signal in the research — and it's the same lever regardless of which GLP-1 you're on.

What this means for your number

None of this changes the target: 1.2–1.6g/kg/day, same as before. What it changes is the stakes. If lean-mass loss can run as high as 60% of total weight lost in some circumstances — and as low as 15% in others — protein intake and resistance training aren't a nice-to-have on top of the medication. They're most of the variance the research can actually explain. Which also makes anything that eats the budget without returning protein worth thinking about — alcohol being the obvious one, and a question the labels turn out not to answer at all.

Calculate your exact target →

By medication

Dose and drug class shift the specifics. See the full breakdown for yours:

Sources

This article summarizes published research for general education. It is not medical advice — talk to your prescriber or a Registered Dietitian about what's right for your situation.

Frequently asked questions

What does the research actually say about protein targets on a GLP-1?
1.2–1.6g per kilogram of body weight per day. This is the same range that shows up across weight-loss protein research generally — GLP-1s don't change the target, they just make it harder to hit because appetite drops so much.
How much muscle do you really lose on a GLP-1?
It varies far more than the commonly-repeated '40%' figure suggests. A 2024 review in Diabetes, Obesity and Metabolism found lean-mass loss ranging from 15% to 60% of total weight lost across different studies, with protein intake and resistance training among the biggest predictors of where any individual lands.
Does resistance training actually prevent muscle loss on Ozempic?
The evidence points that way. A 2025 case series found patients doing resistance training 3–5 days a week while eating 1.6–2.3g of protein per kg of fat-free mass preserved — and in two of three cases, increased — lean tissue while losing weight on semaglutide or tirzepatide. It's a small study, but a larger randomized trial (LEAN-PREP) is now underway testing exactly this.
How do I turn the 1.2–1.6g/kg range into my own number?
Multiply your weight in kilograms by 1.2 for the floor and 1.6 for the ceiling, then divide across 3–4 eating occasions. A 75kg adult lands at 90–120g a day, or roughly 25–35g per meal. The free calculator does the arithmetic and adds a muscle-loss risk score based on your medication and training frequency.

Want this protocol built into your GLP-1 plan?

MALAI does the math, side-effect tracking, and protein architecture for you.

Get started

Continue reading